Streptokinase
CLINICAL USE
Fibrinolytic:Thrombolysis in DVT, PE, acute arterial thromboembolism, acute MI, thrombosed A-V shunts
DOSE IN NORMAL RENAL FUNCTION
Loading dose: 250 000 IU followed by 100 000 IU/hour for 12–72 hours (refer to SPC)Myocardial Infarction: 1.5 MIU followed by aspirinThrombosed
HD                     : shunts: 10–25 000 IU sealed in shunt and repeated after 30–45 minutes PHARMACOKINETICS
Molecular weight                           :47 408 %Protein binding                           :No data %Excreted unchanged in urine     : 0 Volume of distribution (L/kg)       :0.02–0.08half-life – normal/ESRD (hrs)      :18 minutes/– DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Dose as in normal renal function 10 to 20     : Dose as in normal renal function <10           : Dose as in normal renal function DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Not dialysed. Dose as in normal renal function HD                     :Not dialysed. Dose as in normal renal functionHDF/high flux   :Unlikely to be dialysed. Dose as in normal renal functionCAV/VVHD      :Not dialysed. Dose as in normal renal function IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsAnticoagulants should not be given with streptokinaseHeparin infusions should be stopped 4 hours before streptokinase infusion. If this is not possible, protamine sulphate should be used to neutralise the heparin; heparin infusions can be restarted 4 hours post streptokinase infusion followed by oral anticoagulants ADMINISTRATION
Reconstition
See manufacturer’s literature Route
IV Rate of Administration
Give loading dose of 250 000 IU in 100 mL fluid over 30 minutes, followed by an appropriate volume for the maintenance doseGive 1.5 MIU for acute MI in 50–200 mL fluid over 1 hourComments
For occluded HD                     : shunts, add 100 000 IU to 100 mL sodium chloride 0.9% and put 10–25 mL into the clotted portion of the shunt OTHER INFORMATION
There are no significant changes in pharmacokinetics in patients with renal insufficiency. Dosage reduction is therefore not necessary.
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home